Avisi Technologies, a 2020 Rosenman Innovator, raised $4.06 million to accelerate clinical development of its VisiPlate product, an ocular implant […]
$4M Seed Round Focused on Glaucoma Treatment

Avisi Technologies, a 2020 Rosenman Innovator, raised $4.06 million to accelerate clinical development of its VisiPlate product, an ocular implant […]
2019 Rosenman Innovator, Deep Blue Medical Advances, received an additional 510(k) clearance from the FDA for its T-Line Hernia Mesh […]
The FDA recently granted 510(k) clearance to Avenda Health, a Rosenman Innovator company, for its prostate cancer mapping platform. Using […]
Alio, a 2015 Rosenman Innovator, has raised $18 million in a Series C funding round. Specializing in wearable technology for […]
Efemoral Medical, a start-up developing a bioresorbable scaffold designed to treat peripheral arterial disease, closed $4.9M Series A1 fund. The […]
Blumio, a Rosenman Innovator company, has recently been acquired by CardieX. Specializing in wearable sensor technologies for cardiovascular health disorders, […]
Allotrope Medical‘s surgical device, was recently granted FDA Safer Technologies Program (STeP) designation. This designation highlights the value of their […]
This summer, the Rosenman Institute recruited startups for a unique student program for the second year in a row: Foothill’s […]
Enspectra Health, a Rosenman Innovator and RISE company, recently announced its first patients’ enrollment in its virtual skin biopsy study. These non-invasive vivo images have the potential to become a groundbreaking tool for doctors and dermatologists.
care accessible for those most in need, including those with serious and persistent mental illness.” By giving access to virtual mental health treatment for serious illnesses, Valera is hoping to change the scope of the industry.